Angiotensin Peptides and Lung Cancer

By  

Current Cancer Drug Targets, Vol. 11, Iss. 4, 2011-05 ,pp. : 394-404

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Potential of Angiotensin-(1-7) as a Novel Renin- Angiotensin System Mediator

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 5, 2006-05 ,pp. : 603-609

Bentham Science Publishers

Access to resources Recommend Favorite

Angiotensin-(1–7) potentiates responses to bradykinin but does not change responses to angiotensin I

By Master Ryan G.   Fokin Alex   Baber Syed R.   Greco A. J.   Kadowitz Philip J.  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 11, 2006-11 ,pp. : 1163-1175

NRC Research Press

Access to resources Recommend Favorite

Effects of angiotensin IV and angiotensin-(1-7) on basal and angiotensin II-stimulated cytosolic Ca 2+ in mesangial cells

By Chansel D.   Vandermeersch S.   Oko A.   Curat C.   Ardaillou R.  

European Journal of Pharmacology, Vol. 414, Iss. 2, 2001-03 ,pp. : 165-175

Elsevier

Access to resources Recommend Favorite

Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin–angiotensin system: a patent review

By Ferreira Anderson J   Bader Michael   Santos Robson AS  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 567-574

Informa Healthcare

Access to resources Recommend Favorite